Discover how clinical data management in the US has transformed from data collection to a multi-faceted endeavor, driving breakthroughs in biomedical research, diagnostics, drug development, and vaccines. Learn from leading experts, including our Chief Scientific Officer, about the latest advancements and future prospects in this groundbreaking publication.
Clinical trials require a comprehensive approach to ensure quality and efficiency. Quality by Design, Risk-Based Monitoring, and Risk-Based Quality Management work together to achieve these goals, focusing on building quality into the trial process, targeting monitoring activities, and continuously improving trial quality.
This opinion piece by Keith Dorricott, MBB, addresses the challenges faced by the clinical trial industry in implementing QTLs and KRIs as required by ICH E6(R2). The article explores why KRIs have been easier to adopt than QTLs and wonders if the specific guidance provided by ICH E6(R2) is partly responsible.
Explore clinical trial and enrollment activity across countries with ease. Our new eyesON application visualizes data from ClinicalTrials.gov, helping you gain a deeper understanding.
In clinical trials, managing risks that could impact data quality is crucial for ensuring patient safety, data integrity, and regulatory compliance. While Risk-Based Quality Management (RBQM) and Quality Risk Management (QRM) are both approaches designed to manage risks, the two have essential differences.
You won't want to miss our latest press release announcing the cooperation between Cyntegrity and PwC! The collaboration brings together Cyntegrity's cutting-edge technology solutions with PwC's expertise in professional services, data integration, and M&A activities.
We're thrilled to announce that we've passed our SOC 2 Type 2 examination, which confirms our effective controls over confidentiality, privacy, and processing of online cloud platforms. SOC 2 compliance demonstrates our high level of information security and responsible handling of sensitive information.
Looking for a comprehensive RBQM software solution for your clinical trials? Look no further than Cyntegrity, your premier RBQM software vendor. Our suite of RBQM tools is designed to help you proactively manage risk, enhance data privacy and security, and improve the quality and efficiency of your clinical trials. With our user-friendly tools, real-time monitoring and reporting, and dedicated customer support, Cyntegrity is the ultimate choice for all your RBQM software needs. And with the Cyntegrity MyRBQM Academy, you can enhance your RBQM expertise and take your clinical trials to the next level. Choose Cyntegrity as your premier RBQM software provider and transform your clinical trials today.
Exciting news on ICH GCP E6(R3) is here! Our CEO, Artem Andrianov, returned from the SCOPE Summit with updates on the updated guideline. ICH E6(R3) will incorporate technology advancements while prioritizing participant protection and reliable evidence. Don't miss Artem's thoughts on his experience at the summit. Stay tuned for more updates on ICH E6(R3)!
In an interview with Applied Clinical Trials, CEO Artem Andrianov discusses the inspiration behind the tool, its benefits to the industry, and its functionality. The tool is aimed to improve patient outcomes by reducing the risk of negative reactions to combined medications.
